HIGHLIGHTS
- who: Yoichi Kaneuchi and colleagues from the Department of Orthopaedic Surgery, School of Medicine, Fukushima Medical University, Hikarigaoka, Fukushima City, Fukushima, Japan have published the research work: Pregnancy and Lactation-Associated Osteoporosis Successfully Treated with Romosozumab: A Case Report, in the Journal: Medicina 2023, 59, 19. of /2023/
- what: As in the present patient, nausea was cited as one of the major reasons for the difficulty with teriparatide continuation .
SUMMARY
Monoclonal antibody romosozumab, a sclerostin inhibitor, is one of the key drugs used to treat postmenopausal osteoporosis, but the search revealed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.